Peter G. Shields

23.0k citations

331 papers · 14.4k indexed · h-index 66

Impact in

Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment
Physiology top 0.5%
- Smoking Behavior and Cessation

Papers in

Cancer Research 77
- Carcinogens and Genotoxicity Assessment 49
Physiology 80
- Smoking Behavior and Cessation 64

Co-authors: Elise D. Bowman Jo L. Freudenheim Curtis C. Harris Christine B. Ambrosone Neil E. Caporaso Caryn Lerman Janet Audrain Neal R. Boyd
Journals: Cancer Epidemiology Biomarkers & Prevention (35 papers)Cancer Research (12 papers)Carcinogenesis (11 papers)Journal of Clinical Oncology (10 papers)JNCI Journal of the National Cancer Institute (9 papers)
Partner nations: United States Romania Japan

In The Last Decade

Peter G. Shields

323 papers receiving 13.9k citations

Peers

Countries citing papers authored by Peter G. Shields

Since Specialization

Citations

This map shows the geographic impact of Peter G. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Shields more than expected).

Fields of papers citing papers by Peter G. Shields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter G. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Shields. The network helps show where Peter G. Shields may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter G. Shields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter G. Shields Line = papers co-authored together Peter G. Shields links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Depression and Inflammation Predict Depression Trajectory of Non–Small Cell Lung Cancer Patients PubMed ·Navya Kesavan, Peter G. Shields, Jewgenij Singer, Sarah A. Reisinger, Barbara L. Andersen	2025	0
2	mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer Journal for ImmunoTherapy of Cancer ·No‐Joon Song, М М Сенюк, M. V. Ezhov, Chelsea Bolyard, KP Rodbell, Kevin P. Weller, Sarah A. Reisinger, Yi Wang, Marcia Ferreira Amendola, Sizun Jiang, Qin Ma, Dan H. Barouch, Mark P. Rubinstein, Peter G. Shields, Eugene M. Oltz, Dongjun Chung, Zihai Li	2024	5
3	Illegal product purchasing in the experimental tobacco marketplace: Effects of menthol cigarette and cigarette ventilation ban Drug and Alcohol Dependence ·Ckaraborthy Gs, Allison N. Tegge, S. Olyaee, Annalyse Belton, Jeffrey S. Stein, K. Michael Cummings, Geoffrey T. Fong, Peter G. Shields, Dorothy K. Hatsukami, Warren K. Bickel	2023	4
4	Switching to cigarette brand variants with different filter ventilation levels: a descriptive analysis Tobacco Control ·Dana Mowls Carroll, Katelyn Tessier, Xianghua Luo, Irina Stepanov, Peter G. Shields, Richard J. O’Connor, Vaughan W. Rees, K. Michael Cummings, Warren K. Bickel, Dorothy K. Hatsukami	2023	2
5	Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma American Journal of Physiology-Lung Cellular and Molecular Physiology ·Min‐Ae Song, JY Kim, Matthew W. Gorr, Rens Brouwer, Manjula Karpurapu, Jackie Nguyen, Fagner Laviola Valente, Kellie J. Archer, Navjotsingh Pabla, Peter G. Shields, Loren E. Wold, John W. Christman, Sangwoon Chung	2023	7
6	Untargeted Metabolomics and Body Mass in Adolescents: A Cross-Sectional and Longitudinal Analysis Metabolites ·Amarnath Singh, Garrett Kinnebrew, Willeke Slingerland, Daniel Weng, Min‐Ae Song, Sarah A. Reisinger, Joseph P. McElroy, Brittney Keller‐Hamilton, Amy K. Ferketich, Jo L. Freudenheim, Peter G. Shields	2023	4
7	A Pilot Cross-Sectional Study of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles for Smokers, Electronic Cigarette Users, and Never-Smokers Microorganisms ·Peter G. Shields, 闫听, Theodore M. Brasky, Jo L. Freudenheim, Zihai Li, Joseph McElroy, Sarah A. Reisinger, Min‐Ae Song, Liliana Carvalho-Saucedo, Mark D. Wewers, 森口喜成, Yiping Yang, Ewy A. Mathé	2023	5
8	Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer. Health Psychology ·Thomas R Valentine, Carolyn J. Presley, David P. Carbone, Peter G. Shields, Barbara L. Andersen	2022	24
9	Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking Cancer Prevention Research ·闫听, Theodore M. Brasky, Jo L. Freudenheim, Joseph McElroy, A. Peroni, Min‐Ae Song, Daniel Weng, Mark D. Wewers, 森口喜成, Ewy A. Mathé, Peter G. Shields	2022	17
10	Risk perceptions and continued smoking as a function of cigarette filter ventilation level among US youth and young adults who smoke Tobacco Control ·Dana Mowls Carroll, Katelyn Tessier, K. Michael Cummings, Richard J. O’Connor, Sarah A. Reisinger, Peter G. Shields, Irina Stepanov, Xianghua Luo, Dorothy K. Hatsukami, Vaughan W. Rees	2021	6
11	Impact of Cigarette Filter Ventilation on U.S. Smokers' Perceptions and Biomarkers of Exposure and Potential Harm Cancer Epidemiology Biomarkers & Prevention ·Dana Mowls Carroll, Irina Stepanov, Richard J. O’Connor, Xianghua Luo, K. Michael Cummings, Vaughan W. Rees, Warren K. Bickel, Micah L. Berman, David L. Ashley, Maansi Bansal‐Travers, Peter G. Shields, Dorothy K. Hatsukami	2020	12
12	Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description of those with moderate to severe depressive symptoms Lung Cancer ·Barbara L. Andersen, Thomas R Valentine, Stephen Lo, David P. Carbone, Carolyn J. Presley, Peter G. Shields	2019	29
13	Menthol Smokers: Metabolomic Profiling and Smoking Behavior Cancer Epidemiology Biomarkers & Prevention ·央樹亀山, Renny S. Lan, Theodore M. Brasky, Cătălin Marian, Amrita K. Cheema, Habtom W. Ressom, Christopher A. Loffredo, Wallace B. Pickworth, Peter G. Shields	2016	11
14	Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer Cancer Research ·Ewy A. Mathé, Andrew D. Patterson, Majda Haznadar, Soumen Manna, Kristopher W. Krausz, Elise D. Bowman, Peter G. Shields, Jeffrey R. Idle, Philip B. Smith, Katsuhiro Anami, Dickran Kazandjian, Emmanuel Hatzakis, Frank J. Gonzalez, Curtis C. Harris	2014	142
15	Childhood Exposure to Secondhand Smoke and Functional Mannose Binding Lectin Polymorphisms Are Associated with Increased Lung Cancer Risk Cancer Epidemiology Biomarkers & Prevention ·Susan Olivo‐Marston, Ping Yang, Leah E. Mechanic, Elise D. Bowman, Sharon R. Pine, Christopher A. Loffredo, Anthony J. Alberg, Neil E. Caporaso, Peter G. Shields, Stephen J. Chanock, Yanhong Wu, Ruoxiang Jiang, Julie M. Cunningham, Jin Jen, Curtis C. Harris	2009	46
16	Surveillance Methods for Identifying, Characterizing, and Monitoring Tobacco Products: Potential Reduced Exposure Products as an Example Cancer Epidemiology Biomarkers & Prevention ·Richard J. O’Connor, K. Michael Cummings, Vaughan W. Rees, Gregory N. Connolly, 公行堀, David Sweanor, Mark Parascandola, Dorothy K. Hatsukami, Peter G. Shields	2009	22
17	Clinical Trials Methods for Evaluation of Potential Reduced Exposure Products Cancer Epidemiology Biomarkers & Prevention ·Dorothy K. Hatsukami, Karen L. Hanson, Marie-Hélène Girolet, Mark Parascandola, Jeanine M. Genkinger, Richard J. O’Connor, Peter G. Shields	2009	33
18	Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation Clinical Pharmacology & Therapeutics ·Caryn Lerman, Rachel F. Tyndale, Freda Patterson, E. Paul Wileyto, Peter G. Shields, António Pinto, Neal L. Benowitz	2006	225
19	Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. PubMed ·Kirsten B. Moysich, Peter G. Shields, Jo L. Freudenheim, Enrique F. Schisterman, John E. Vena, Paul J. Kostyniak, Hebe B. Greizerstein, James R. Marshall, Saxon Graham, Christine B. Ambrosone	1999	121
20	Theorizing policy: a framework for the study of U.S. telecommunications regulation / OhioLink ETD Center (Ohio Library and Information Network) ·Peter G. Shields	1994	1

About Peter G. Shields

Peter G. Shields is a scholar working on Cancer Research, Physiology, Oncology, Health, Toxicology and Mutagenesis and Applied Psychology, having authored 331 papers that have together received 14.4k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (64 papers), Carcinogens and Genotoxicity Assessment (49 papers), Epigenetics and DNA Methylation (40 papers), Cancer Risks and Factors (31 papers), Glutathione Transferases and Polymorphisms (30 papers), DNA Repair Mechanisms (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Nicotinic Acetylcholine Receptors Study (17 papers). The work is most often cited by research in Cancer Research (3.0k citations), Physiology (3.5k citations), Oncology (2.8k citations), Health, Toxicology and Mutagenesis (1.4k citations) and Molecular Biology (6.4k citations). Peter G. Shields has collaborated with scholars based in United States, Romania and Japan. Frequent co-authors include Elise D. Bowman, Jo L. Freudenheim, Curtis C. Harris, Christine B. Ambrosone, Neil E. Caporaso, Caryn Lerman, Janet Audrain, Neal R. Boyd, E. Paul Wileyto and David Main. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Cancer Research, Carcinogenesis, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact